- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT06854718
Smärta med demens (PWD)
Caregiver-assisterad smärtprickande kompetensutbildning för demenspilotstudie
The purpose of the study is to develop a caregiver-assisted pain coping skills training program for older adults who have pain and mild to moderate dementia and are living at home with a family caregiver. The investigators are planning to recruit 30 patient-caregiver dyads (60 individuals).
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Involving caregivers in a pain coping skills protocol is likely to optimize treatment outcomes in several ways.
First, people with dementia (PWD) are likely to have difficulty learning and remembering pain coping skills; training the caregiver to coach the patient in the use of the skills is likely to improve the patients' acquisition and ongoing use of learned skills.
Second, caregiver involvement in pain coping skills training may increase their understanding of how to gauge how much pain the PWD is experiencing and the impact of pain management strategies. This understanding is increasingly important as the patient's disease progresses, and s/he is less able to report pain verbally.
Third, caregiver-assisted pain management training may enhance caregivers' self-confidence for managing the patient's pain.
Finally, by participating in the pain coping skills training protocol, caregivers may learn coping skills (such as relaxation) that can help them manage the stress associated with caring for a PWD and pain which can be significant.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
North Carolina
-
Durham, North Carolina, Förenta staterna, 27705
- Duke University Medical Center
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
Patients:
- Mild or moderate dementia
- Pain on most days for at least 3 months that interferes with function
- Living at home (non-institutional)
- Age ≥ 50
- English Speaking
Caregivers:
- Provides on average at least 4 hours/day of care/assistance to the patient
- Age ≥ 18
- English Speaking
Exclusion Criteria:
Patient and caregivers
- Lacking capacity for interview or unable to provide informed consent/assent.
- Visual or hearing impairments or severe behavioral problems that preclude participation.
- Too sick to participate.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Stödjande vård
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Övrig: Patient-Caregiver Dyads
Patient and caregiver dyads will receive five 45-60 minute sessions over 6-8 week period. This will be over videoconference with a masters-level therapist. All sessions will be audio recorded. |
Patient-caregiver dyads will receive five, forty-to-sixty-minute sessions over a six-to-eight-week period with a therapist to learn pain coping skills. These include training caregivers in strategies for assessing patient pain, including nonverbal pain behaviors (e.g., grimacing, bodily tension, labored breathing), which will become increasingly important as the patient's ability to express pain verbally decreases. The therapist will also train the caregiver to coach the patient in the use of the skills during activities that are challenging because of pain. We will focus on increasing positive patient-caregiver interactions and patient engagement in valued activities. Throughout the training, the therapist will help the patient and caregiver learn strategies for fostering regular home practice and application of the skills, identify challenges in using the skills, and find strategies for coping with challenges. |
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Client Satisfaction Questionnaire
Tidsram: Post-intervention (approximately 8 weeks)
|
Caregiver completes. Score range: 1-4; higher score indicates better outcome |
Post-intervention (approximately 8 weeks)
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Quality of life in Alzheimer's Disease Caregiver version and Patient version
Tidsram: Baseline and post-intervention (approximately 8 weeks)
|
Patient and Caregiver will complete Patient QOL. Score range: 13-52; higher score indicates better outcome |
Baseline and post-intervention (approximately 8 weeks)
|
|
Brief Pain Inventory-Interference Items
Tidsram: Baseline and post-intervention (approximately 8 weeks)
|
Patient and Caregiver will complete Patient pain interference. Score range: 0-10; higher score indicates worse outcome |
Baseline and post-intervention (approximately 8 weeks)
|
|
Caregiver Self-Efficacy in Pain Management
Tidsram: Baseline and post-intervention (approximately 8 weeks)
|
Caregiver will complete caregiver self-efficacy. Score range: 0-10; higher score indicates better outcome |
Baseline and post-intervention (approximately 8 weeks)
|
|
Numeric pain scale & verbal descriptor
Tidsram: Baseline and post-intervention (approximately 8 weeks)
|
Patient will complete patient pain intensity. Score range: 0-19; higher score indicates worse outcome |
Baseline and post-intervention (approximately 8 weeks)
|
|
Checklist of nonverbal pain indicators
Tidsram: Baseline and post-intervention (approximately 8 weeks)
|
Caregiver will complete patient pain intensity. Score range: 0-10; higher score indicates worse outcome |
Baseline and post-intervention (approximately 8 weeks)
|
|
Zarit burden interview
Tidsram: Baseline and post-intervention (approximately 8 weeks)
|
Caregivers will complete caregiver burden. Score range: 0-88; higher score indicates worse outcome |
Baseline and post-intervention (approximately 8 weeks)
|
|
Caregiver appraisal-satisfaction scale
Tidsram: Baseline and post-intervention (approximately 8 weeks)
|
Caregiver will complete caregiver satisfaction. Score range: 0-10; higher score indicates worse outcome |
Baseline and post-intervention (approximately 8 weeks)
|
|
Neuropsychiatric inventory
Tidsram: Baseline and post-intervention (approximately 8 weeks)
|
Caregiver will complete patient neuropsychiatry behaviors. Score range: 0-144; higher score indicates worse outcome |
Baseline and post-intervention (approximately 8 weeks)
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Laura Porter, Ph.D, Duke University
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
- Neurologiska manifestationer
- Hjärnsjukdomar
- Sjukdomar i centrala nervsystemet
- Sjukdomar i nervsystemet
- Mentala störningar
- Neoplasmer
- Immunsystemets sjukdomar
- Neoplasmer efter histologisk typ
- Neurokognitiva störningar
- Lymfatiska sjukdomar
- Lymfoproliferativa störningar
- Immunproliferativa störningar
- Lymfom, icke-Hodgkin
- Lymfom
- Patologiska tillstånd, tecken och symtom
- Tecken och symtom
- Hemiska och lymfsjukdomar
- Smärta
- Lymfom, follikulärt
- Demens
Andra studie-ID-nummer
- Pro00116129
- 1R61AG088938-01 (U.S.S. NIH-anslag/kontrakt)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .